Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.

Hamadeh IS, Klinker KP, Borgert SJ, Richards AI, Li W, Mangal N, Hiemenz JW, Schmidt S, Langaee TY, Peloquin CA, Johnson JA, Cavallari LH.

Pharmacogenet Genomics. 2017 May;27(5):190-196. doi: 10.1097/FPC.0000000000000277.

PMID:
28306618
2.

Impact of Long-Term Proton Pump Inhibitor Therapy on Gut Microbiota in F344 Rats: Pilot Study.

Shin CM, Kim N, Kim YS, Nam RH, Park JH, Lee DH, Seok YJ, Kim YR, Kim JH, Kim JM, Kim JS, Jung HC.

Gut Liver. 2016 Nov 15;10(6):896-901. doi: 10.5009/gnl15529.

3.

PMK-S005 Alleviates Age-Related Gastric Acid Secretion, Inflammation, and Oxidative Status in the Rat Stomach.

Choi YJ, Kim N, Lee JY, Nam RH, Suh JH, Lee SM, Ham MH, Jo HJ, Shim YK, Park YH, Lee JC, Choi YJ, Lee HS, Lee DH.

Gut Liver. 2016 Sep 15;10(5):749-56. doi: 10.5009/gnl15584.

4.

Effects of proton pump inhibitors and histamine-2 receptor antagonists on response to fidaxomicin or vancomycin in patients with Clostridium difficile-associated diarrhoea.

Weiss K, Louie T, Miller MA, Mullane K, Crook DW, Gorbach SL.

BMJ Open Gastroenterol. 2015 Mar 2;2(1):e000028. doi: 10.1136/bmjgast-2014-000028. eCollection 2015.

5.

Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.

Antoniou T, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Garg AX, Paterson JM, Juurlink DN.

CMAJ Open. 2015 Apr 2;3(2):E166-71. doi: 10.9778/cmajo.20140074. eCollection 2015 Apr-Jun.

6.

Risk of Stroke-Associated Pneumonia With Acid-Suppressive Drugs: A Population-Based Cohort Study.

Ho SW, Hsieh MJ, Yang SF, Yeh YT, Wang YH, Yeh CB.

Medicine (Baltimore). 2015 Jul;94(29):e1227. doi: 10.1097/MD.0000000000001227.

7.

Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.

Samuels T, Hoekzema C, Gould J, Goldblatt M, Frelich M, Bosler M, Lee SH, Johnston N.

Ann Otol Rhinol Laryngol. 2015 Nov;124(11):893-902. doi: 10.1177/0003489415590657. Epub 2015 Jun 15.

8.

Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.

Herzig SJ, Doughty C, Lahoti S, Marchina S, Sanan N, Feng W, Kumar S.

Ann Neurol. 2014 Nov;76(5):712-8. doi: 10.1002/ana.24262. Epub 2014 Sep 17.

9.

Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications.

Heidelbaugh JJ.

Ther Adv Drug Saf. 2013 Jun;4(3):125-33. doi: 10.1177/2042098613482484.

10.

Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?

Durand C, Willett KC, Desilets AR.

Clin Med Insights Gastroenterol. 2012 Oct 15;5:65-76. doi: 10.4137/CGast.S9588. eCollection 2012. Review.

11.

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.

Zou JJ, Chen SL, Tan J, Lin L, Zhao YY, Xu HM, Lin S, Zhang J, Fan HW, Xie HG.

PLoS One. 2014 Jan 8;9(1):e84985. doi: 10.1371/journal.pone.0084985. eCollection 2014.

12.

Perseverant, non-indicated treatment of obese patients for obstructive lung disease.

Fortis S, Kittah J, De Aguirre M, Plataki M, Wolff A, Amoateng-Adjepong Y, Manthous CA.

BMC Pulm Med. 2013 Nov 22;13:68. doi: 10.1186/1471-2466-13-68.

13.

Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study.

Haroon M, Yasin F, Gardezi SK, Adeeb F, Walker F.

JRSM Short Rep. 2013 Jun 25;4(8):2042533313497183. doi: 10.1177/2042533313497183. eCollection 2013.

14.

Use of acid suppressive therapy in hospitalized non-critically ill patients.

Sheikh-Taha M, Alaeddine S, Nassif J.

World J Gastrointest Pharmacol Ther. 2012 Dec 6;3(6):93-6. doi: 10.4292/wjgpt.v3.i6.93.

15.

Overutilization of proton-pump inhibitors: what the clinician needs to know.

Heidelbaugh JJ, Kim AH, Chang R, Walker PC.

Therap Adv Gastroenterol. 2012 Jul;5(4):219-32. doi: 10.1177/1756283X12437358.

16.

Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis.

Rashid S, Rajan D, Iqbal J, Lipka S, Jacob R, Zilberman V, Shah M, Mustacchia P.

ISRN Gastroenterol. 2012;2012:902320. doi: 10.5402/2012/902320. Epub 2012 May 31.

17.

Pharmacy student impact on inappropriate prescribing of acid suppressive therapy.

Carey KM, Cross JE, Silva MA, Stefan MS, Rothberg MB.

Am J Pharm Educ. 2011 Nov 10;75(9):175. doi: 10.5688/ajpe759175.

18.

Stress ulcer prophylaxis guidelines: Are they being implemented in Lebanese health care centers?

Zeitoun A, Zeineddine M, Dimassi H.

World J Gastrointest Pharmacol Ther. 2011 Aug 6;2(4):27-35. doi: 10.4292/wjgpt.v2.i4.27.

19.

Proton pump inhibitor-associated pneumonia: Not a breath of fresh air after all?

Fohl AL, Regal RE.

World J Gastrointest Pharmacol Ther. 2011 Jun 6;2(3):17-26. doi: 10.4292/wjgpt.v2.i3.17.

20.

Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.

Yu EW, Bauer SR, Bain PA, Bauer DC.

Am J Med. 2011 Jun;124(6):519-26. doi: 10.1016/j.amjmed.2011.01.007.

Supplemental Content

Support Center